Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Various Advanced Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01236352
What this trial is testing

Multiple Ascending Dose of BMS-911543

Who this might be right for
Cancer
Bristol-Myers Squibb 98
Not applicableWithdrawnNCT04889495
What this trial is testing

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

Who this might be right for
Non-small Cell Lung CancerMetastatic Colorectal CancerMetastatic Breast Cancer+5 more
Pfizer
Not applicableStudy completedNCT03350529
What this trial is testing

MRI Guided Transurethral HIFU for Various Prostate Diseases

Who this might be right for
Localised Prostate CancerLocally Advanced Prostate CancerLocally Recurrent Prostate Cancer+1 more
Turku University Hospital 87
Early research (Phase 1)Looking for participantsNCT05067283
What this trial is testing

Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

Who this might be right for
Advanced Solid Tumors
Merck Sharp & Dohme LLC 830
Testing effectiveness (Phase 2)Ended earlyNCT05525247
What this trial is testing

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination

Who this might be right for
Advanced Solid Tumor
Selecxine 27
Early research (Phase 1)Study completedNCT01403974
What this trial is testing

Phase I Trial of BI 836845 for Various Solid Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 61
Testing effectiveness (Phase 2)Study completedNCT03130959
What this trial is testing

Evaluate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Participants With High Grade Primary Central Nervous System (CNS) Malignancies

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 166
Early research (Phase 1)Study completedNCT01007968
What this trial is testing

Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 25
Not applicableLooking for participantsNCT05443087
What this trial is testing

TARGETed Therapy Drug MONITOring in DIGestive Oncology

Who this might be right for
Digestive CancerMetastatic Colorectal CancerHepatocellular Carcinoma+2 more
UNICANCER 330
Early research (Phase 1)Study completedNCT00621725
What this trial is testing

Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours

Who this might be right for
Advanced CancerHepatic Impairment
AstraZeneca 36
Large-scale testing (Phase 3)Study completedNCT00536081
What this trial is testing

Various G-CSF Regimens to Prevent Infection During Chemotherapy

Who this might be right for
Breast CancerChemotherapyFebrile Neutropenia
Academisch Ziekenhuis Maastricht 172
Testing effectiveness (Phase 2)Study completedNCT01700049
What this trial is testing

Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes

Who this might be right for
Basal Cell Carcinoma
Mayo Clinic 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT03473743
What this trial is testing

Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Janssen Research & Development, LLC 125
Early research (Phase 1)Study completedNCT00046423
What this trial is testing

A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies

Who this might be right for
NeoplasmsMetastases, Neoplasm
Celgene Corporation 20
Early research (Phase 1)Study completedNCT03335540
What this trial is testing

An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 20
Early research (Phase 1)Not Yet RecruitingNCT07664397
What this trial is testing

Imaging Study of [89Zr]DFO-YS5 for Cancer Detection

Who this might be right for
Bladder CancerNerve Sheath TumorNerve Sheath Tumors+9 more
Robert Flavell, MD, PhD 40
Early research (Phase 1)Study completedNCT00701324
What this trial is testing

BI 811283 in Various Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 124
Testing effectiveness (Phase 2)UnknownNCT02689167
What this trial is testing

Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma

Who this might be right for
Kidney NeoplasmsMetastatic Renal Cell Cancer
Centre Hospitalier Universitaire de Besancon 226
Not applicableLooking for participantsNCT07312760
What this trial is testing

Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)

Who this might be right for
Advanced Cancer, Various, NOS
Universitätsklinikum Hamburg-Eppendorf 160
Early research (Phase 1)Study completedNCT00884546
What this trial is testing

Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma

Who this might be right for
Advanced Cancer, Various, NOS
Bristol-Myers Squibb 27
Next Page